Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
Clinical Trial
[키워드] Analysis
ANOVA
applied
can be used
Chi-square
clinical status
Complication
conducted
Convalescent CP recipient
convalescent plasma
Convalescent plasma (CP)
correlated
COVID pneumonia
COVID-19
COVID-19 pandemic
COVID-19 patient
criterion
Critical
critical cases
Cytokine storm
death
disease
Disease progression
Endpoint
Enrollment
expired
Fisher’s exact test
FIVE
hospitalized patients
interquartile ranges
invasive ventilation
lung infiltrates
lung infiltration
Mann-Whitney U test
median
median age
median time
multiorgan failure
non-randomized
onset of symptom
open label
oxygen saturation
parameter
Patient
patients
potential therapy
recipient
recipients
registration date
Result
Safe
SARS CoV2 infection
severe adverse events
severe patients
severity
SOFA
SOFA score
SPSS
Study design
transfused
Treatment
Trial
Trial registration
ventilator
[DOI] 10.1186/s12879-021-06451-7 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1186/s12879-021-06451-7 PMC 바로가기 [Article Type] Clinical Trial